Repligen (RGEN) Revenue (2010 - 2026)

Repligen (RGEN) has 17 years of Revenue data on file, last reported at $194.3 million in Q1 2026.

• On a quarterly basis, Revenue rose 14.83% year-over-year to $194.3 million in Q1 2026; TTM through Mar 2026 was $763.3 million, a 17.36% increase from a year earlier, with the FY2025 full-year figure at $738.3 million, up 16.36% from the prior year.
• Revenue for Q1 2026 stood at $194.3 million, down from $197.9 million in the prior quarter.
• Over the last five years, Revenue for RGEN reached as high as $207.6 million in Q2 2022 and fell as low as $141.2 million in Q3 2023.
• Historically, Revenue has averaged $176.5 million across 5 years, with a median of $169.2 million in 2025.
• Across the five-year window, Revenue jumped 44.5% in 2022 and fell 29.66% in 2023, its largest moves.
• Year by year, Revenue stood at $186.8 million in 2022, then decreased by 10.78% to $166.6 million in 2023, then advanced by 0.56% to $167.5 million in 2024, then grew by 18.12% to $197.9 million in 2025, then fell by 1.85% to $194.3 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $194.3 million in Q1 2026, $197.9 million in Q4 2025, and $188.8 million in Q3 2025.